Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Neoplasms of the CNS

Free Subscription 26.10.2026 1 Am J Clin Oncol 3 BMC Cancer 1 BMC Neurol 1 Cancer Res 1 Int J Cancer 1 Int J Radiat Oncol Biol Phys 8 J Neurooncol 2 J Neuropathol Exp Neurol 6 Neuro Oncol 4 Neuroradiology 1 Oncogene 1 Proc Natl Acad Sci U S A 1 Radiol Artif Intell

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Clin Oncol

1. GORANTLA N, Kinslow CJ, Kim DK, Ashji G, et al
   Patient-Facility Distance and Adjuvant Radiotherapy for WHO Grade 2-3 Meningioma.
   Am J Clin Oncol. 2026 Oct 16. doi: 10.1097/COC.0000000000001388.
   PubMed         Abstract available
   
   

   
   BMC Cancer

2. ZHANG X, Sui J, Sun H, Chai R, et al
   RBFOX3 is associated with neuronal-like phenotypic transition in recurrent glioblastoma.
   BMC Cancer. 2026;26:1271.
   PubMed         Abstract available
   
   
3. MENG J, Jiang X, Hu Y, Tian J, et al
   EIF3B is associated with m(6)A-related regulation of E2F7 and promotes stemness in glioblastoma multiforme.
   BMC Cancer. 2026;26:1270.
   PubMed         Abstract available
   
   
4. ZHAO S, He S, Zhou Y, Fan Y, et al
   Clinicopathologic features and prognostic factors of breast cancer brain metastases patients based on molecular subtypes: a real-world retrospective analysis.
   BMC Cancer. 2026;26:1275.
   PubMed         Abstract available
   
   

   
   BMC Neurol

5. WANG L, Wen X, Zeng S, Yu Z, et al
   Intradural extramedullary venous hemangioma mimicking meningioma: a case report and literature review.
   BMC Neurol. 2026;26:660.
   PubMed         Abstract available
   
   

   
   Cancer Res

6. TAGLANG C, Batsios G, Gillespie AM, Phillips JJ, et al
   PHGDH Sustains Oncometabolite Production to Drive Resistance to Mutant IDH Inhibition in Glioma that can be Monitored by Metabolic Imaging.
   Cancer Res. 2026 Oct 22. doi: 10.1158/0008-5472.CAN-25-4071.
   PubMed         Abstract available
   
   

   
   Int J Cancer

7. IVREN M, Dao Trong P, Klass M, Dugas M, et al
   Early Postoperative Adverse Events (
   Int J Cancer. 2026;159:2962-2972.
   PubMed         Abstract available
   
   

   
   Int J Radiat Oncol Biol Phys

8. PHAM TN, Azemar N, Mathis T, Delattre G, et al
   Multivariable Normal Tissue Complication Probability Prediction of Early Grade Radiation-Induced Optic Neuropathy Using Visual Field Deficit in a Prospective Pencil Bean Scanning Proton Therapy Cohort.
   Int J Radiat Oncol Biol Phys. 2026;126:949-960.
   PubMed         Abstract available
   
   

   
   J Neurooncol

9. GUERRINI F, D'Agata F, Musella V, Vitali A, et al
   Postoperative DWI morphology and neurological worsening after eloquent-area glioma surgery: a retrospective cohort study.
   J Neurooncol. 2026;180:23.
   PubMed         Abstract available
   
   
10. MONIRUZZAMAN S, Rantala S, Hakumaki J, Rauramaa T, et al
    Incidence of intra-axial brain metastases in Eastern Finland.
    J Neurooncol. 2026;180:24.
    PubMed         Abstract available
    
    
11. LECHPAMMER M, Norrell JT, Parnas JN, Vojnic M, et al
    Opportunities and challenges of artificial intelligence and digital pathology in adult CNS tumors.
    J Neurooncol. 2026;180:25.
    PubMed         Abstract available
    
    
12. YOGENDRAN LV, Avery C, Crooms RC, Ozair A, et al
    Artificial intelligence for symptom assessment and patient-reported outcomes in neuro-oncology.
    J Neurooncol. 2026;180:26.
    PubMed         Abstract available
    
    
13. ZIDAN A, El-Sherbini A, Burns L, Soliman H, et al
    Artificial intelligence in gamma knife radiosurgery: applications in treatment planning, response prediction, and toxicity assessment.
    J Neurooncol. 2026;180:27.
    PubMed         Abstract available
    
    
14. SAINI J, Lozano C, Karthikeyan V, Shakil H, et al
    Neighborhood material deprivation and days at home after glioblastoma diagnosis.
    J Neurooncol. 2026;180:28.
    PubMed         Abstract available
    
    
15. MAHMOUDI DA, Kite T, Singh E, McKenna A, et al
    Urgent versus scheduled resection in high-grade glioma: patient selection and healthcare utilization in a single-center cohort.
    J Neurooncol. 2026;180:29.
    PubMed         Abstract available
    
    
16. YU MC, Hsi AH, Adnan A, Knight SR, et al
    MEK inhibitors in NF1-associated high-grade glioma: partial responses and outcomes from a single-institution cohort and literature review.
    J Neurooncol. 2026;180:30.
    PubMed         Abstract available
    
    

    
    J Neuropathol Exp Neurol

17. LIN C, Lin P, Huang N, Min J, et al
    gp96 knockdown inhibits the malignant behaviors of glioblastoma cells by suppressing the NF-kappaB pathway.
    J Neuropathol Exp Neurol. 2026 Oct 21:nlag111. doi: 10.1093.
    PubMed         Abstract available
    
    
18. GESTRICH CK, Patel S, Shroff SM, Goodman A, et al
    Primary intracranial sarcoma, DICER1-mutant: 5 cases highlighting variable clinical and molecular features.
    J Neuropathol Exp Neurol. 2026;85:1323-1331.
    PubMed         Abstract available
    
    

    
    Neuro Oncol

19. 
    Corrigendum to: Homeobox A3 and KDM6A cooperate in transcriptional control of aerobic glycolysis and glioblastoma progression.
    Neuro Oncol. 2026 Oct 19:noag242. doi: 10.1093.
    PubMed        
    
    
20. ZHANG X, Guo X, Wang Y, Wagstyl K, et al
    MRI-Based Machine Learning to Differentiate True Progression from Pseudoprogression in Glioblastoma: An Updated Systematic Review and Meta-Analysis.
    Neuro Oncol. 2026 Oct 19:noag259. doi: 10.1093.
    PubMed         Abstract available
    
    
21. HO SZW, Lu RO
    Tuning CAR-T Cell Fitness Through Tonic Signaling in Diffuse Midline Glioma.
    Neuro Oncol. 2026 Oct 19:noag250. doi: 10.1093.
    PubMed        
    
    
22. YOU M, Xie T, Wu L, Liu J, et al
    Firmonertinib 160mg in EGFR-Mutated NSCLC with Brain Metastases After EGFR-TKI Resistance (iFORCE): Clinical Outcomes and Mechanistic Insights.
    Neuro Oncol. 2026 Oct 20:noag260. doi: 10.1093.
    PubMed         Abstract available
    
    
23. YE H, Qiu J, Zhu F, Quan R, et al
    EGFRvIII-Positive Glioblastoma: Structural Rewiring, Immune Microenvironmental Remodeling, and Therapeutic Resistance.
    Neuro Oncol. 2026 Oct 22:noag266. doi: 10.1093.
    PubMed         Abstract available
    
    
24. LE RHUN E, Mellinghoff IK, Weiss T, Neidert MC, et al
    Biomarker-guided treatment strategies for patients with gliomas in clinical practice.
    Neuro Oncol. 2026 Oct 19:noag238. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Neuroradiology

25. MACULA A, Morana G, Coppola F, Garnero A, et al
    Deep learning for contrast-enhanced MRI in pediatric brain imaging.
    Neuroradiology. 2026 Jul 4. doi: 10.1007/s00234-026-04073.
    PubMed         Abstract available
    
    
26. FIRAT Z, Ekinci G, Ture U
    MR elastography and perfusion MRI characterize distinct biomechanical and vascular features of meningiomas.
    Neuroradiology. 2026 Oct 17. doi: 10.1007/s00234-026-04217.
    PubMed         Abstract available
    
    
27. BATALOV AI, Zakharova NE, Elagina NE, Pogosbekyan EL, et al
    Diagnostic value of 3D pCASL perfusion in glioma grading according to the WHO 2021 classification: a retrospective study of 530 cases.
    Neuroradiology. 2026 Oct 19. doi: 10.1007/s00234-026-04225.
    PubMed         Abstract available
    
    
28. BATALOV AI, Afandiev RM, Zakharova NE, Lebedenko AV, et al
    CT Perfusion in the differential diagnosis of glioblastomas and primary central nervous system lymphomas.
    Neuroradiology. 2026 Oct 21. doi: 10.1007/s00234-026-04233.
    PubMed         Abstract available
    
    

    
    Oncogene

29. XU H, Huang Y, Su D, Hong B, et al
    Dual novel compounds destroy mitochondrial morphology and function to treat glioblastoma by promoting the p62-mediated protein degradation of mitochondrial respiratory chain complex.
    Oncogene. 2026 Oct 16. doi: 10.1038/s41388-026-04018.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

30. BURCHETT DARANTIERE A, Zarodniuk M, Giza S, Rexroat J, et al
    Multi-omics and spatial analysis of microgravity-grown glioblastoma organoids reveal superior modeling of advanced disease after long-term spaceflight.
    Proc Natl Acad Sci U S A. 2026;123:e2616218123.
    PubMed         Abstract available
    
    

    
    Radiol Artif Intell

31. JABAL MS, Zhang J, LaBella D, Houk JL, et al
    Agentic Automation of BT-RADS Scoring Using an End-to-End System for Standardized Glioma Follow-up Assessment.
    Radiol Artif Intell. 2026 Oct 21:e260234. doi: 10.1148/ryai.260234.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Neoplasms of the CNS is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum